Pharmacokinetics of Antiretrovirals in Pregnant Women
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 43 (15), 1071-1087
- https://doi.org/10.2165/00003088-200443150-00002
Abstract
Antiretroviral treatment of HIV-infected pregnant women is widely used to prevent mother-to-child HIV transmission and as primary therapy of maternal HIV infection. The physiological changes...Keywords
This publication has 91 references indexed in Scilit:
- Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV InfectionClinical Pharmacokinetics, 1999
- TheEx Vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavirInfectious Diseases in Obstetrics and Gynecology, 1998
- Pharmacokinetic Changes During Pregnancy and Their Clinical RelevanceClinical Pharmacokinetics, 1997
- LamivudineDrugs, 1997
- Protease Inhibitors in Patients with HIV DiseaseClinical Pharmacokinetics, 1997
- Review of β-Lactam Antibiotics in PregnancyClinical Pharmacokinetics, 1994
- Clinical Pharmacokinetics of ZidovudineClinical Pharmacokinetics, 1989
- Plasma Protein Binding of Drugs in PregnancyClinical Pharmacokinetics, 1982
- Pharmacokinetics of Ampicillin during PregnancyThe Journal of Infectious Diseases, 1977
- Interactions of various 19-nor steroids with human placental microsomal cytochrome P-450 (P-450hpm)Chemico-Biological Interactions, 1976